A Unique Approach to Treating Neuromuscular Disorders
Tivorsan Pharmaceuticals is a protein therapeutics company pioneering a unique approach to treat serious neuromuscular disorders, including Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD).
- Tivorsan Pharmaceuticals Granted FDA Orphan Drug Designation for Human Recombinant Biglycan in the Treatment of Duchenne Muscular Dystrophy
- Tivorsan Pharmaceuticals closes private placement funds to support R&D of Biglycan for Duchenne Muscular Dystrophy
- Tivorsan Pharmaceuticals Names Business Leader James E. Connolly as CEO and Board Member